57 Tumours of the Pharynx • Subsites Soft palate—anterior pillar lateral, posterior hard palate, free margin inferior including uvular Base of tongue—anterior margin is circumvallate papilla, posterior is vallecular Tonsil—most common • 2% of all H&N malignancy • 80% SCC • Minor salivary gland tumours (present submucosal) with adenoid cystic most common • Uvular involvement or disease involving midline consider bilateral neck treatment • High rate of occult metastases (20–30%) including retropharyngeal nodes • Velopharyngeal insufficiency with nasal regurgitation can occur following surgical resection • Radiotherapy ± chemotherapy is treatment of choice for most lesions • Post-radiotherapy recurrence and larger tumours surgical treatment includes lip-split, mandibulotomy with preincision plating, floor of mouth incision extending posteriorly, including division of mylohyoid, to gain maximum exposure • Tumour resection with radial forearm free flap reconstruction and covering tracheostomy • Aetiology HPV (better prognosis P16 positive) Smoking • SCC most common (Fig. 57.1) followed by lymphoma • Presents with ulceration or asymmetrical tonsil enlargement or lymphadenopathy ± previous presentations • Metastases to neck nodes levels 2 and 3 most common and often cystic (misdiagnosed as branchial cysts) • Trismus indicates pterygoid muscle involvement • Features May present late due to symptoms misinterpreted as infection Submucosal disease may make primary easily missed on examination Palpation of tongue base is vital part of examination and consider general anaesthesia ± biopsy if the gag reflex is too strong but clinically suspicious Can present as metastatic neck disease of unknown primary Need to assess relation to midline and hence whether ipsilateral or bilateral neck requires treatment • Treatment Surgery, radiotherapy, or chemoradiotherapy There is a significant impact on speech and swallowing function with all treatment options, particularly with large disease Mandibulotomy for access may be required Consider supplementary feeding via gastrostomy before or after treatment • Staging T0: no evidence of primary tumour T1: tumour ≤ 2 cm T2: tumour 2–4 cm T3: tumour >4 cm T4a: tumour invades adjacent structures, e.g., cortical bone mandible, hard palate, larynx, and deep muscles of tongue T4b: tumour invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, skull base, or encases carotid artery • Posterior pharyngeal wall—superior level of hyoid bone to inferior border of cricoid • Piriform fossa (Fig. 57.2)—pharyngoepiglottic fold to upper oesophagus • Postcricoid space (Fig. 57.3)—arytenoid cartilages to inferior border of cricoid cartilage
57.1 Oropharynx
57.1.1 Soft Palate
57.1.2 Tonsil
57.1.3 Tongue Base
57.2 Hypopharynx
57.2.1 Subsites
< div class='tao-gold-member'>
Stay updated, free articles. Join our Telegram channel
Tumours of the Pharynx
Only gold members can continue reading. Log In or Register a > to continue